- Home
- VSECU vs PRCT Comparison
VSECU vs PRCT Comparison
Compare VSECU & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VSECU | PRCT |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | 1600 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | VSECU | PRCT |
|---|---|---|
| Price | $47.80 | $28.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $35.44 |
| AVG Volume (30 Days) | 25.3K | ★ 1.4M |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | N/A | $31.34 |
| Revenue Next Year | N/A | $24.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $38.45 | $19.35 |
| 52 Week High | $65.93 | $64.89 |
Technical Indicators
Market Signals| Indicator | VSECU | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 57.45 |
| Support Level | $44.42 | $22.05 |
| Resistance Level | $58.80 | $29.18 |
| Average True Range (ATR) | 3.18 | 1.84 |
| MACD | 0.30 | 0.04 |
| Stochastic Oscillator | 26.36 | 69.81 |
Price Performance
Historical ComparisonAbout VSECU VSE Corporation Tangible Equity Units
VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.